Torres, Lidiane de Souza [UNESP]Silva, Danilo Grünig Humberto da [UNESP]Belini Junior, Edis [UNESP]Almeida, Eduardo Alves de [UNESP]Lobo, Clarisse Lopes de CastroCançado, Rodolfo DelfiniRuiz, Milton ArturBonini-Domingos, Claudia Regina [UNESP]2014-05-202014-05-202012-01-01Revista Brasileira de Hematologia e Hemoterapia. Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, v. 34, n. 6, p. 421-425, 2012.1516-8484http://hdl.handle.net/11449/21452OBJECTIVE: The oxidative stress in 20 sickle cell anemia patients taking hydroxyurea and 13 sickle cell anemia patients who did not take hydroxyurea was compared with a control group of 96 individuals without any hemoglobinopathy. METHODS: Oxidative stress was assessed by thiobarbituric acid reactive species production, the Trolox-equivalent antioxidant capacity and plasma glutathione levels. RESULTS: Thiobarbituric acid reactive species values were higher in patients without specific medication, followed by patients taking hydroxyurea and the Control Group (p < 0.0001). The antioxidant capacity was higher in patients taking hydroxyurea and lower in the Control Group (p = 0.0002 for Trolox-equivalent antioxidant capacity and p < 0.0292 for plasma glutathione). Thiobarbituric acid reactive species levels were correlated with higher hemoglobin S levels (r = 0.55; p = 0.0040) and lower hemoglobin F concentrations(r = -0.52; p = 0.0067). on the other hand, plasma glutathione levels were negatively correlated with hemoglobin S levels (r = -0.49; p = 0.0111) and positively associated with hemoglobin F values (r = 0.56; p = 0.0031). CONCLUSION: Sickle cell anemia patients have high oxidative stress and, conversely, increased antioxidant activity. The increase in hemoglobin F levels provided by hydroxyurea and its antioxidant action may explain the reduction in lipid peroxidation and increased antioxidant defenses in these individuals.421-425engHemoglobinopathiesOxidative stressSickle cell anemiaHydroxyureaArtigo10.5581/1516-8484.20120106S1516-84842012000600010Acesso abertoS1516-84842012000600010.pdf67134008663822553279428066176719